To Evaluate the Effect of Reveratrol,Folic Acid, Vitamin D, Vitamin B12 and B6 in Male Infertility

Launched by UNIVERSITY OF PERUGIA · Mar 3, 2019

Keywords

ClinConnect Summary

This is a single-centre prospective observational study. Twenty infertile male patients.

Inclusion criteria are:

Age:18-50 years oligozoospermia: \< 5 million spermatozoa/mL; asthenozoospermia: \< 32% progressive motile spermatozoa; teratozoospermia: \< 4% normal forms.

Esclusion criteria:

Patients with azoospermia, who smoke, use drugs, drugs with proven fertility toxicity, exposed to any environmental or occupational toxic substances, radiation or heat; with orchitis secondary to mumps, sexually transmitted diseases, history of cryptorchidism, previous testicular torsion, genitourinar...

Gender

MALE

Eligibility criteria

• Inclusion Criteria:
• • male 18-50 years
• • oligozoospermia: \< 5 million spermatozoa/mL;
• • asthenozoospermia: \< 32% progressive motile spermatozoa;
• • teratozoospermia: \< 4% normal forms.
• Exclusion Criteria:
• • azoospermia
• • smoke
• • use drugs
• • use drugs with proven fertility toxicity
• • exposition to any environmental or occupational toxic substances
• • exposition to radiation or heat
• • orchitis secondary to mumps
• • sexually transmitted diseases
• • history of cryptorchidism
• • previous testicular torsion
• • genitourinary anomalies
• • alterations of the epididymis or deferens
• • inguinal surgery